efgartigimod-hyaluronidase (Vyvgart Hytrulo), ravulizumab (Ultomiris), rozanolixizumab (Rystiggo), or Soliris (eculizumab) [package insert].
Ultomiris is also being investigated in phase 3 studies for the treatment of coronavirus disease 2024 (COVID-19). Ultomiris [package insert]. Boston, MA: Alexion Pharmaceuticals; 2024.
Package insert for ULTOMIRIS for Intravenous Infusion 300 mg. [Online]. Available: 12. Package insert for
Dilute Ultomiris dose in Sodium Chloride 0.9% as directed by vial size in package insert. if Ultomiris maintenance dose not administered. Other. □______
Ultomiris [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc.; June 2024. 2. Parker CJ. Management of paroxysmal nocturnal
US Food and Drug Administration (FDA). Center for Drug Evaluation and Research. Drugs @ FDA. Ravulizumab- cwvz (Ultomiris). Package insert.
package insert for appropriate dosing. § Adult patients with Ultomiris [package insert]. Boston, MA; Alexion Pharmaceuticals, Inc
Ultomiris. Jcode: J1303. NDCs: Uplizna. Jcode: J1823. NDCs: V. Veopoz. Jcode Alyglo [package insert]. Teaneck, NJ: GC Biopharma USA, Inc.; December 2024
Ultomiris [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc, 2024. 2. Kaplan BS, Ruebner RL, Spinale JM, Copelovitch L. Current
I would like to know more about this package. ^.^